High-quality cancer care: Summary of an institute of medicine workshop

Journal of Oncology Practice

Volumn 9, Issue 6 SUPPL., 2013, Pages

  Balogh, Erin P ^{a,b,c,d,e,f,g,h,i}   Bach, Peter B ^{a,b,c,d,e,f,g,h,i}   Eisenberg, Peter D ^{a,b,c,d,e,f,g,h,i}   Ganz, Patricia A ^{a,b,c,d,e,f,g,h,i}   Green, Robert J ^{a,b,c,d,e,f,g,h,i}   Gruman, Jessie C ^{a,b,c,d,e,f,g,h,i}   Nass, Sharyl J ^{a,b,c,d,e,f,g,h,i}   Newcomer, Lee N ^{a,b,c,d,e,f,g,h,i}   Ramsey, Scott D ^{a,b,c,d,e,f,g,h,i}   Schottinger, Joanne E ^{a,b,c,d,e,f,g,h,i}   Shih, Ya Chen Tina ^{a,b,c,d,e,f,g,h,i}  

^a Center for the Advancement of Health   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Marin Specialty Care   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAISER PERMANENTE   (United States)

^f Cancer Clinics of Excellence   (United States)

^g UNITEDHEALTH GROUP   (United States)

^h USA   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER THERAPY; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; PATIENT ATTITUDE; REIMBURSEMENT; REVIEW; TERMINAL CARE; UNITED STATES;

EID: 84897056903     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001123     Document Type: Review

References (60)

1. Congressional Budget Office: The 2012 long-term budget outlook, Pub. No. 4507. Washington, DC, US Government Printing Office, 2012
2. Milstein A: Code red and blue-Safely limiting health care's GDP footprint. N Engl J Med 368:1-3, 2013
3. Emanuel E, Tanden N, Altman S, et al: A systemic approach to containing health care spending. N Engl J Med 367:949-954, 2012
4. Bipartisan Policy Center: What is driving U.S. health care spending? http://bipartisanpolicy.org/sites/default/files/ BPC%20Health%20Care%20Cost%20Drivers%20Brief%20Sept%202012.pdf
5. Emanuel EJ, Fuchs VR: Who really pays for health care? The myth of "shared responsibility." JAMA 299:1057-1059, 2008
6. Sullivan R, Peppercorn J, Sikora K, et al: Delivering affordable cancer care in high-income countries. Lancet Oncology 12:933-980, 2011
7. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
8. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-128, 2011
9. Institute of Medicine and National Research Council: Ensuring Quality Cancer Care. Washington, DC, National Academies Press, 1999
10. Institute of Medicine: Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care: Workshop Summary. Washington, DC: National Academies Press, 2011
11. Blayney DW, Severson J, Martin CJ, et al: Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care. Health Aff (Millwood) 31:718-728, 2012
12. Institute of Medicine: Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC, National Academies Press, 2013
13. Goodwin JS, Singh A, Reddy N, et al: Overuse of screening colonoscopy in the Medicare population. Arch Intern Med 171:1335-1343, 2011
14. Tan A, Kuo YF, Elting LS, et al: Refining physician quality indicators for screening mammography in older women: Distinguishing appropriate use from overuse. J Am Geriatr Soc 61:380-387, 2013
15. Sheffield KM, Han Y, Kuo YF, et al: Potentially inappropriate screening colonoscopy in Medicare patients: Variation by physician and geographic region. JAMA Int Med 173:542-550, 2013
16. Haas JS, Phillips KA, Liang SY, et al: Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care 17:e174-e181, 2011
17. Guadagnolo BA, Liao KP, Elting L, et al: Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31:80-87, 2012
18. Smith GL, Shih YC, Xu Y, et al: Racial disparities in the use of radiation therapy following breast conserving surgery: A national Medicare study. Cancer 116:734-741, 2010
19. American Cancer Society: Cancer Facts & Figures 2011. Atlanta, GA, American Cancer Society, 2011
20. Ward E, Halpern M, Schrag N, et al: Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9-31, 2008
21. Institute of Medicine: Delivering Affordable Cancer Care in the 21st Century: Workshop Summary. Washington, DC, National Academies Press, 2013
22. Institute of Medicine: Medicare: A Strategy for Quality Assurance. Washington, DC, National Academies Press, 1990
23. Etheredge LM: Medicare's future: Cancer care. Health Aff (Millwood) 28:148-159, 2009
24. Council of Economic Advisors: The economic case for health care reform, 2009. www.whitehouse.gov/administration/eop/cea/ TheEconomicCaseforHealthCareReform
25. Institute of Medicine: Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC, National Academies Press, 2012
26. Bach PB: Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med 360:626-633, 2009
27. Soares M: "Off-label" indications for oncology drug use and drug compendia: History and current status. J Oncol Pract 1:102-105, 2005
28. Conti RM, Bernstein AC, Villaflor VM, et al: Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a populationbased cohort of medical oncologists. J Clin Oncol 31:1134-1139, 2013
29. Abernethy AP, Coeytaux RR, Carson K, et al: Report on the Evidence Regarding Off-Label Indications for Targeted Therapies Used in Cancer Treatment: Technology Assessment Report. Rockville, MD, Agency for Healthcare Research and Quality, 2010
30. Smith GL, Xu Y, Buchholz TA, et al: Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 307:1827-1837, 2012
31. Earle CC, Neville BA, Landrum MB, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004
32. Weeks JC, Catalano PJ, Cronin A, et al: Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367:1616-1625, 2012
33. Yun YH, Lee CG, Kim SY, et al: The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol 22:307-314, 2004
34. Lamont EB, Christakis NA: Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096-1105, 2001
35. Smith TJ, Dow LA, Virago E, et al: Giving honest information to patients with advanced cancer maintains hope. Oncology (Williston Park) 24:521-525, 2010
36. Weeks JC, Cook EF, O'Day SJ, et al: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714, 1998
37. Bernard DS, Farr SL, Fang Z: National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29:2821-286, 2011
38. Shankaran V, Jolly S, Blough D, et al: Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 30:1608-1614, 2012
39. Ramsey S, Blough D, Kirchhoff A, et al: Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32:1143-1152, 2013
40. Mandl KD, Kohane IS: Escaping the EHR trap-The future of health IT. N Engl J Med 366:2240-2242, 2012
41. Fox J: The hidden role of cost: Medicare decisions, transparency and public trust. U Cincinnati Law Rev 79:1-51, 2011
42. Tunis SR: Why Medicare has not established criteria for coverage decisions. N Engl J Med 350:2196-2198, 2004
43. Newcomer LN: Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs. Health Aff (Millwood) 31:780-785, 2012
44. Bach PB, Mirkin JN, Luke JJ: Episode-based payment for cancer care: A proposed pilot for Medicare. Health Aff (Millwood) 30:500-509, 2011
45. Agency for Healthcare Research and Quality: Patient centered medical home resource center, 2011. http://pcmh.ahrq.gov/portal/server.pt/community/pcmh- home/1483/what-is-pcmh-
46. Sprandio JD: Oncology patient-centered medical home. J Oncol Pract 8:47s-49s, 2012
47. Accretive Health: Accretive Health and Cancer Clinics of Excellence to Develop Innovative Program Providing Oncology Care Management. http://ir.accretivehealth.com/phoenix.zhtml?c-234481&p-irol- newsArticle&ID-1729915&highlight-
48. Smith TJ, Hillner BE: Bending the cost curve in cancer care. N Engl J Med 364:2060-2065, 2011
49. Smith TJ: Tell it like it is. J Clin Oncol 21:12s-16s, 2003
50. Meropol NJ, Schrag D, Smith TJ, et al: American Society of Clinical Oncology guidance statement: The cost of cancer care. J Clin Oncol 27:3868-3874, 2009
51. Gesme DH, Wiseman M: A financial counselor on the practice staff: A winwin. J Oncol Pract 7:273-275, 2011
52. ABIM Foundation: Choosing Wisely, 2013. www.abimfoundation.org/ Initiatives/Choosing-Wisely.aspx
53. Schnipper LE, Smith TJ, Raghavan D, et al: American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol 30:1715-1724, 2012
54. Neubauer MA, Hoverman JR, Kolodziej M, et al: Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract 6:12-18, 2010
55. Hoverman JR, Cartwright TH, Patt DA, et al: Pathways, outcomes, and costs in colon cancer: Retrospective evaluations in 2 distinct databases. Am J Manag Care 17:SP45-SP52, 2011 (suppl 5)
56. Greer JA, Pirl WF, Jackson VA, et al: Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30:394-400, 2012
57. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733-742, 2010
58. Abernethy AP, Etheredge LM, Ganz PA, et al: Rapid-learning system for cancer care. J Clin Oncol 28:4268-4274, 2010
59. Jacobson M, Earle CC, Price M, et al: How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) 29:1391-1399, 2010
60. Colla CH, Morden NE, Skinner JS, et al: Impact of payment reform on chemotherapy at the end of life. J Oncol Pract 8:e6s-e13s, 2012